Rubius Therapeutics Inc (Over The Counter Market:RUBY)
| 0.0191 Delayed Data As of Dec 01 |  0.00 / 0.00%Today’s Change | 0.00 Today|||52-Week Range 0.42 | -89.09% Year-to-Date |
Latest RUBY News | Press Releases
No recent news for Rubius Therapeutics Inc.
Today’s Trading
| Previous close | 0.02 |
| Today’s open | 0.02 |
| Day’s range | 0.02 - 0.02 |
| Volume | 17,010 |
| Average volume (3 months) | 54,733 |
| Market cap | $1.7M |
Data as of 12/01/2023
Growth & Valuation
| Earnings growth (last year) | +10.98% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 0.11 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Optigenex Inc | 0.00 | 0.00% |
| GPLLBenchmark Energy Cor... | 0.00 | 0.00% |
| PLXProtalix Biotherapeu... | -0.04 | -2.65% |
| OTLCOncotelic Therapeuti... | -0.00 | -5.11% |
Data as of 3:59pm ET, 12/01/2023
Financials
| Last reporting date | November 16, 2022 |
| EPS forecast (this quarter) | -$0.42 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$179.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foxboro, Massachusetts |
Forecasts
Chart unavailable
